Ir al contenido principal
European Network of Centres for Pharmacoepidemiology and Pharmacovigilance
Artículo1 de agosto de 2014Agencia Europea de Medicamentoslectura de 1 min

New PROTECT benefit-risk website

The Pharmacoepidemiological Research on Outcomes of Therapeutics by a European Consortium (PROTECT) contains a number of work programmes whose goal is to strengthen the benefit-risk monitoring of medicines in Europe. Work program 5 (Benefit-Risk group) of PROTECT has developed a new website on available methods for benefit-risk evaluation and representation. It includes supporting tools and recommendations for use of benefit-risk methodologies and intends to be a guide for readers who are new to the world of benefit-risk assessment.

Related information:

» PROTECT benefit-risk website

» PROTECT project

Detalles

Fecha de publicación
1 de agosto de 2014
Autor
Agencia Europea de Medicamentos